July 29, 2010

Study: HIV Meds Will Cost Global Fund Nearly $2B Yearly

The Global Fund to Fight AIDS, Tuberculosis and Malaria will need to spend between $1.6 billion and $1.9 billion per year to provide ongoing support to the 2.5 million people it already provides with antiretroviral (ARV) therapy, according to a study released at the XVIII International AIDS Conference in Vienna and reported by aidsmap.com. The Global Fund plans to increase the number of people it provides with ARVs to 3.5 million by the end of 2011.

To read the aidsmap.com article, click here.

Search: The Global Fund, International AIDS Conference, Vienna, ARV therapy, ART

Scroll down to comment on this story.